✦ LIBER ✦

Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen

✍ Scribed by Tsuyoshi Itoh, Yuji Ueda, Ichiro Kawashima, Ikuei Nukaya, Hitoshi Fujiwara, Nobuaki Fuji, Tetsuro Yamashita, Tetsunori Yoshimura, Kaori Okugawa, Tomoko Iwasaki, Mitsuko Ideno, Kazutoh Takesako, Masakazu Mitsuhashi, Kunzo Orita, Hisakazu Yamagishi

Book ID: 105966519
Publisher: Springer-Verlag
Year: 2002
Tongue: English
Weight: 130 KB
Volume: 51
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s00262-001-0257-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of HLA-A24-restricted peptides

Analysis of HLA-A24-restricted peptides of carcinoembryonic antigen using a novel structure-based peptide-HLA docking algorithm

✍ Yoji Nakamura; Sachiko Tai; Chie Oshita; Akira Iizuka; Tadashi Ashizawa; Shuji S 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB

Analysis of HLA-A24-restricted peptides

Analysis of HLA-A24-restricted peptides of carcinoembryonic antigen using a novel structure-based peptide-HLA docking algorithm

✍ Yoji Nakamura; Sachiko Tai; Chie Oshita; Akira Iizuka; Tadashi Ashizawa; Shuji S 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 799 KB

Induction of specific CTL by MAGE-3/CEA

Induction of specific CTL by MAGE-3/CEA peptide-pulsed dendritic cells from HLA-A2/A24+gastrointestinal cancer patients

✍ Xishan Hao; Ying Shao; Xiubao Ren; Hong Liu; Qi Xu; Hui Li; Peng Zhang; Xiumei A 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 181 KB

Report of immune monitoring of prostate

Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)

✍ Salgaller, Michael L.; Lodge, Patricia A.; McLean, Joanne G.; Tjoa, Ben A.; Loft 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB 👁 2 views

## BACKGROUND. In this paper we describe our program for the immune monitoring of phase II participants given dendritic cell (DC)/prostate-specific membrane antigen (PSMA)-based immunotherapy, and we also present some initial findings. METHODS. Phase II subjects received six administrations of aut

Phase I clinical trial: T-cell therapy f

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

✍ Murphy, G.; Tjoa, B.; Ragde, H.; Kenny, G.; Boynton, A. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 791 KB

## BACKGROUND. Conventional treatment for metastatic prostate cancer have failed to demonstrate curative potential in all patients. Investigations involving the role of T-cell immunity in the clearance of neoplastic cells are now available. Development of T-cell immunotherapy may give a new approa

Induction of human leukocyte antigen (HL

Induction of human leukocyte antigen (HLA)-A2-restricted and MAGE-3-gene-derived peptide-specific cytolytic T lymphocytes using cultured dendritic cells from an HLA-A2 esophageal cancer patient

✍ Kanaoka, Shunji; Yamasaki, Seiji; Okino, Takashi; Inoue, Naoya; Shimada, Yutaka; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

## Background and objectives: Using peripheral blood mononuclear cells (pbmcs) from a 10-year survivor with established human leukocyte antigen (hla)-a2(+) and mage-3(+) esophageal cancer cell line (kyse-170), we examined the induction of hla-a2-restricted and mage-3-gene-derived peptide (flwgpralv